Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
place 1 tablet on tongue; tablet disintegrates, with or without water adults and children 6 years and over 1 tablet every 12 hours; not more than 2 tablets in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
safety sealed: do not use if the individual blister unit imprinted with Claritin® RediTabs® is open or torn store between 20° to 25°C (68° to 77°F) use tablet immediately after opening individual blister complies with USP Procedure 2 for Assay and Organic Impurities and Test 2 for Disintegration
Drug Facts
Loratadine 5 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
Do not use if you have ever had an allergic reaction to this product or any of its ingredients.
Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product do not take more than directed. Taking more than directed may cause drowsiness.
Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 6 years and over | 1 tablet every 12 hours; not more than 2 tablets in 24 hours |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
anhydrous citric acid, gelatin, mannitol, mint flavor
1-800-CLARITIN (1-800-252-7484) or
www.claritin.com
Distributed by MSD Consumer Care, Inc.,
PO Box 377, Memphis, TN 38151 USA,
a subsidiary of Merck & Co., Inc., Whitehouse Station, NJ USA.
NDC 11523-7202-3
Non-Drowsy*
Claritin
®
RediTabs
®
loratadine
5 mg/antihistamine
Indoor & Outdoor
Allergies
*When taken as directed. See Drug Facts Panel.
12
Hour
Relief of:
No Water Needed
Melts in Your Mouth
10
ORALLY
DISINTEGRATING TABLETS
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 904026 | Claritin RediTabs 5 MG 12HR Disintegrating Oral Tablet | PSN | 12 |
| 672558 | loratadine 5 MG Disintegrating Oral Tablet | PSN | 12 |
| 904026 | loratadine 5 MG Disintegrating Oral Tablet [Claritin] | SBD | 12 |
| 672558 | loratadine 5 MG Disintegrating Oral Tablet | SCD | 12 |
| 904026 | Claritin 12HR RediTabs 5 MG Disintegrating Oral Tablet | SY | 12 |
| 904026 | Claritin 5 MG Disintegrating Oral Tablet | SY | 12 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11523-7202-1 | ClaritinReditabs | 3 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 3 | 12 | |
| 11523-7202-1 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7202-3 | ClaritinReditabs | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 12 | |
| 11523-7202-3 | ClaritinReditabs | 1 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 1 | 12 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 11523-7202-1 | EA - Each | 11523-7202 | 2d9569c3-1d2b-4a96-a48f-54e4ce505bd9 | 1 | 2012-07-24 |
| 11523-7202-3 | EA - Each | 11523-7202 | 8c62db1c-bc79-4bd8-aae5-46837fb33bf9 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Loratadine | ACTIVE INGREDIENT | 7AJO3BO7QN | 4 | |
| Loratadine | ACTIVE MOIETY | 7AJO3BO7QN | 4 | |
| anhydrous citric acid | INACTIVE INGREDIENT | XF417D3PSL | 4 | |
| gelatin | INACTIVE INGREDIENT | 2G86QN327L | 4 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11523-7202 | 11523-7202-1, 11523-7202-3 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| GELATIN | 2G86QN327L | IACT |
| MANNITOL | 3OWL53L36A | IACT |
| LORATADINE | 7AJO3BO7QN | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / ORAL | 117 mg | ||
| gelatin | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / ORAL | 120 mg | ||
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / ORAL | 117 mg | ||
| gelatin | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / ORAL | 120 mg | ||
| mannitol | MANNITOL | 3OWL53L36A | TABLET, ORALLY DISINTEGRATING / ORAL | 4364 mg | ||
| gelatin | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / ORAL | 120 mg | ||
| mannitol | MANNITOL | 3OWL53L36A | TABLET, ORALLY DISINTEGRATING / ORAL | 4364 mg | ||
| anhydrous citric acid | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / ORAL | 117 mg | ||
| mannitol | MANNITOL | 3OWL53L36A | TABLET, ORALLY DISINTEGRATING / ORAL | 4364 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021993-001 | CLARITIN REDITABS | LORATADINE | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021993-001 | CLARITIN REDITABS | 5MG | TABLET, ORALLY DISINTEGRATING / ORAL | RLD, RS | 2006-12-12 | 3bdfa0b2c4d7… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Claritin Reditabs | LORATADINE | Bayer HealthCare LLC | 7dc04b48-f053-4e4b-a493-9e8286d2a791 | 2025-12-05 | Warnings | 11523-7202-3 11523-7202-1 11523-7202 11523720203 11523720201 45371bc6-b83d-a96d-e063-6294a90a7c40 7dc04b48-f053-4e4b-a493-9e8286d2a791 |
Adverse event summaries are temporarily unavailable. Other product information remains available.